Literature DB >> 727763

Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate.

K Stenberg, A Larsson.   

Abstract

The antiviral compound trisodium phosphonoformate (PFA), which inhibits herpesvirus multiplication by 50% at a concentration of 10 muM, did not show any effects on macromolecular synthesis and cell proliferation in HeLa and human lung cells at this concentration. At the high concentration of 2 mM, PFA reduced DNA synthesis to 50% after 1 h of treatment, whereas no effects could be seen on RNA and protein synthesis. Treatment for 24 h with 1 mM PFA inhibited both DNA synthesis and cell proliferation to 50%. The inhibition of DNA synthesis and cell proliferation at 10 mM PFA was rapidly reversed by removing the drug from the cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727763      PMCID: PMC352541          DOI: 10.1128/AAC.14.5.727

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Trisodium phosphonoformate, a new antiviral compound.

Authors:  E Helgstrand; B Eriksson; N G Johansson; B Lannerö; A Larsson; A Misiorny; J O Norén; B Sjöberg; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Science       Date:  1978-09-01       Impact factor: 47.728

2.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.

Authors:  S Alenius; Z Dinter; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate.

Authors:  C L Sabourin; J M Reno; J A Boezi
Journal:  Arch Biochem Biophys       Date:  1978-04-15       Impact factor: 4.013

5.  Reversible inhibition of cellular metabolism by ribavirin.

Authors:  A Larsson; K Stenberg; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

  5 in total
  6 in total

1.  Concentration-dependent effects of foscarnet on the cell cycle.

Authors:  K Stenberg; S Skog; B Tribukait
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

2.  Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

3.  Phosphonoformate inhibition of visna virus replication.

Authors:  B Sundquist; E Larner
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

Review 4.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

5.  Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).

Authors:  F Villinger; E V Genovesi; D J Gerstner; T C Whyard; R C Knudsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.

Authors:  J Schnürer; B Oberg
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.